The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls
- PMID: 30669509
- PMCID: PMC6358997
- DOI: 10.3390/ijms20020433
The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls
Abstract
Psyllium is a widely used treatment for constipation. It traps water in the intestine increasing stool water, easing defaecation and altering the colonic environment. We aimed to assess the impact of psyllium on faecal microbiota, whose key role in gut physiology is being increasingly recognised. We performed two randomised, placebo-controlled, double-blinded trials comparing 7 days of psyllium with a placebo (maltodextrin) in 8 healthy volunteers and 16 constipated patients respectively. We measured the patients' gastrointestnal (GI) transit, faecal water content, short-chain fatty acid (SCFA) and the stool microbiota composition. While psyllium supplement had a small but significant effect on the microbial composition of healthy adults (increasing Veillonella and decreasing Subdoligranulum), in constipated subjects there were greater effects on the microbial composition (increased Lachnospira, Faecalibacterium, Phascolarctobacterium, Veillonella and Sutterella and decreased uncultured Coriobacteria and Christensenella) and alterations in the levels of acetate and propionate. We found several taxa to be associated with altered GI transit, SCFAs and faecal water content in these patients. Significant increases in three genera known to produce butyrate, Lachnospira, Roseburia and Faecalibacterium, correlated with increased faecal water. In summary, psyllium supplementation increased stool water and this was associated with significant changes in microbiota, most marked in constipated patients.
Keywords: constipation; ispaghula; microbiome; prebiotics; transit.
Conflict of interest statement
GM: speakers fees from Allergan and Vertex. RS: research funding from research funding from LeSaffre, Norgine, Ironwood and Zespri Group Ltd. He has also acted on advisory boards for Napo Pharmaceuticals, Commonwealth International, Yuhan Corporation, Ibsen, Danone and Almirall, and received speakers’ fees from Menarini and Alfawasserman. IS-S, CK and JF: employees of Ironwood Pharmaceuticals Inc. at the time of the study. Other authors have nothing relevant to declare. The funders had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures
References
-
- Pollet A., Van Craeyveld V., Van de Wiele T., Verstraete W., Delcour J.A., Courtin C.M. In Vitro Fermentation of Arabinoxylan Oligosaccharides and Low Molecular Mass Arabinoxylans with Different Structural Properties from Wheat (Triticum aestivum L.) Bran and Psyllium (Plantago ovata Forsk) Seed Husk. J. Agric. Food Chem. 2012;60:946–954. doi: 10.1021/jf203820j. - DOI - PubMed
-
- Campbell J.M., Fahey G.C. Psyllium and methylcellulose fermentation properties in relation to insoluble and soluble fiber standards. Nutr. Res. 1997;17:619–629. doi: 10.1016/S0271-5317(97)00034-1. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
